Biogen (BIIB) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Biogen (BIIB) stock.

Latest Upgrades and Downgrades for Biogen Stock

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Piper Sandler	David Amsellem	PT Raise	Overweight	$245→$305
—	Guggenheim	Yatin Suneja	PT Raise	Buy	$280→$300
—	HC Wainwright & Co.	Ananda Ghosh	PT Raise	Buy	$251→$270
—	Canaccord Genuity	Sumant Kulkarni	PT Raise	Buy	$248→$272
—	Argus Research	Jasper Hellweg	Upgrade	Hold→Buy	$280
—	RBC Capital	Brian Abrahams	PT Raise	Outperform	$256→$272
—	Morgan Stanley	Matthew Harrison	PT Raise	Equal-Weight	$231→$238
—	UBS	Michael Yee	PT Raise	Buy	$270→$300
—	TD Cowen	Phil Nadeau	PT Raise	Buy	$250→$260
—	Wedbush	Laura Chico	PT Raise	Neutral	$212→$225
—	Truist Securities	Danielle Brill	PT Raise	Buy	$235→$260
—	Baird	Brian Skorney	PT Raise	Outperform	$250→$290
—	Needham	Ami Fadia	PT Raise	Buy	$256→$290
—	Barclays	Emily Field	PT Raise	Equal-Weight	$200→$230
—	B of A Securities	Jason Zemansky	PT Raise	Neutral	$219→$244
—	TD Cowen	Phil Nadeau	PT Raise	Buy	$225→$250
—	Wells Fargo	Mohit Bansal	PT Raise	Overweight	$250→$310
—	JP Morgan	Chris Schott	Upgrade	Neutral→Overweight	$210→$300
—	UBS	Michael Yee	PT Raise	Buy	$240→$270
—	RBC Capital	Brian Abrahams	PT Cut	Outperform	$260→$256